Does Aetna cover GLP-1 medications?
commercial
Aetna (a CVS Health company) is one of the largest US commercial health insurers, with ~22 million members.
What Aetna specifically requires
- Wegovy's first approval runs 7 months and requires at least 6 months in a comprehensive weight management program before starting (policy 4774-C). Aetna Wegovy prior authorization policy 4774-C, May 1, 2024
- Zepbound's first approval runs 8 months; renewal requires at least 3 months on a stable maintenance dose and 5% weight loss from baseline (policy 6192-C). Aetna Zepbound prior authorization policy 6192-C, Dec 19, 2024
- CVS Caremark removed Zepbound from its formulary effective July 1, 2025 and named Wegovy as the covered alternative. Massachusetts GIC: CVS Caremark removes Zepbound from its formulary, Jun 10, 2025
- Aetna keeps a separate Wegovy policy for cardiovascular risk reduction (6410-C), apart from its weight-loss policy. Aetna Wegovy (cardiovascular) policy 6410-C, Mar 2024
- Wegovy supply limit: one box of 4 pens per 21 days, or 3 boxes per 63 days (policy 4774-C). Aetna Wegovy prior authorization policy 4774-C, May 1, 2024
Aetna coverage by drug
- Covered (prior auth required)Wegovysemaglutide
Aetna's Wegovy policy (4774-C) approves adults with a baseline BMI of 30 or more, or 27 or more with a weight-related condition, after at least 6 months in a comprehensive weight management program. The first approval lasts 7 months. Whether your plan includes weight-loss drugs at all depends on your plan.
- Limited coverageZepboundtirzepatide
CVS Caremark, the pharmacy benefit manager in Aetna's parent company CVS Health, removed Zepbound from its formulary on July 1, 2025 and lists Wegovy as the covered alternative. If your Aetna plan uses that formulary, Zepbound needs a formulary exception. Aetna's Zepbound policy (6192-C) sets the clinical bar at BMI 30, or 27 with a weight-related condition, plus 6 months in a weight management program.
- CoveredOzempicsemaglutide
Ozempic is FDA-approved for type 2 diabetes, not for weight loss. We have not found a public Aetna coverage document for Ozempic, so confirm coverage, prior authorization and tier on your plan's drug list or by calling the number on your insurance card.
- CoveredMounjarotirzepatide
Mounjaro is FDA-approved for type 2 diabetes, not for weight loss. We have not found a public Aetna coverage document for Mounjaro, so confirm coverage, prior authorization and tier on your plan's drug list or by calling the number on your insurance card.
- Covered (prior auth required)Saxendaliraglutide
Saxenda is FDA-approved for chronic weight management. We have not found a public Aetna coverage document for Saxenda, so confirm coverage, prior authorization and tier on your plan's drug list or by calling the number on your insurance card.
- CoveredZoloftsertraline
Generic sertraline is a widely used generic antidepressant. Check your plan's drug list for its tier and copay.
- CoveredLexaproescitalopram
Generic escitalopram is a widely used generic antidepressant. Check your plan's drug list for its tier and copay.
- Limited coverageViagrasildenafil
Many plans limit or exclude drugs for erectile dysfunction. Check your plan's drug list for quantity limits and prior authorization; cash-pay generic sildenafil can cost less than a copay.
- Limited coverageCialistadalafil
Plans may treat tadalafil for benign prostatic hyperplasia (BPH) differently from tadalafil for erectile dysfunction. Check your plan's drug list for the use you are prescribed.
- Not coveredPropeciafinasteride
Plans that cover finasteride usually do so for benign prostatic hyperplasia (5 mg). The 1 mg dose for hair loss is often treated as cosmetic. Check your plan's drug list.
Reminder: coverage varies by plan
Aetna offers many plan designs. The same medication can be covered under one Aetna plan and excluded from another. Always confirm with your specific plan's formulary or call the number on your insurance card before assuming coverage.
Frequently asked
Does Aetna cover GLP-1 medications for weight loss?+
Aetna's published Wegovy and Zepbound policies require a BMI of 30 or more (or 27 or more with a weight-related condition) and at least 6 months in a weight management program. Plans that use the CVS Caremark formulary have excluded Zepbound since July 1, 2025, with Wegovy as the covered alternative. GLP-1 coverage at Aetna varies plan by plan. For Wegovy and Zepbound (weight-loss indications), expect prior authorization at minimum, with formal documentation of BMI and previous lifestyle interventions. For Ozempic and Mounjaro (type 2 diabetes), coverage is generally easier when prescribed for diabetes.
Does Aetna require a prior authorization for Wegovy or Zepbound?+
Yes, prior authorization (PA) is the norm for weight-loss GLP-1s across Aetna plans. A PA typically requires documented BMI ≥30 (or ≥27 with a comorbidity), prior attempts at structured weight loss, and sometimes step-therapy through cheaper alternatives. Your prescriber's office files the PA.
How do I check if my specific Aetna plan covers a drug?+
Three steps: (1) Log into your Aetna member portal and search the drug formulary by name. (2) Call the member services number on your insurance card. (3) Ask your prescriber to submit a benefits inquiry. Plan designs differ widely within Aetna — what's covered for one member may not be covered for another.
What if Aetna denies my GLP-1 prior authorization?+
Three options: (1) Appeal — most plans grant an appeal that adds physician peer-to-peer review; your prescriber can request this. (2) Switch indication if clinically appropriate (e.g., if you have prediabetes and BMI ≥30, your physician may have different coverage paths). (3) Use manufacturer direct-pay (NovoCare, LillyDirect) which doesn't depend on insurance approval.
Are compounded GLP-1s covered by Aetna?+
Generally no. Most insurance plans, including Aetna, do not cover compounded semaglutide or tirzepatide regardless of pharmacy. As of 2026, the FDA is winding down large-scale compounding, so coverage questions are increasingly moot — most patients are transitioning to branded GLP-1s or manufacturer direct-pay programs.